Ovarian Function Suppression With Luteinizing Hormone-Releasing Hormone Agonists for the Treatment of Hormone Receptor-Positive Early Breast Cancer in Premenopausal Women
10.3389/fonc.2021.700722
Saved in:
Main Authors: | Lu, Yen-Shen, Wong, Andrea, Kim, Hee-Jeong |
---|---|
Other Authors: | MEDICINE |
Format: | Review |
Published: |
Frontiers Media S.A.
2022
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/232401 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Use of hormone replacement therapy before and after ovarian cancer diagnosis, and ovarian cancer survival
by: Mascarenhas, C., et al.
Published: (2015) -
Urinary Luteinizing Hormone (LH) Levels in Male Athletes during 3 – Years Routine Doping Control Analysis at the NDCC Bangkok
by: Asawesna C., et al.
Published: (2019) -
Mechanisms of hormonally-induced transcription of LHBeta subunit gene in its chromatin setting
by: KOH MINGSHI
Published: (2010) -
Molecular variants of luteinizing hormone in three populations of Southeast Asia
by: Ramanujam, L., et al.
Published: (2013) -
Malignant ovarian germ-cell tumours
by: Low, J.J.H., et al.
Published: (2016)